A Paradigm Shift to Realize Intelligent Clinical Trial Oversight

The usual approach of adding technology and headcount to manage today’s clinical trials is not sustainable or scalable. In this webinar, Nick Dyer (CEO, Catalyst Clinical Research) discusses the challenges his team has experienced with complex early phase oncology studies, and why they chose Medidata’s CTMS to help Catalyst attain operational success.

Stacey Yount (VP of Product – Trial Management Solutions, Medidata) will also discuss how Rave CTMS delivers expected efficiencies and more importantly, enables you to be effective.

You will learn how to:

  • Cut through the data noise and make smarter decisions
  • Break down the silos and improve collaboration
  • “See” issues and remediate before they become big problems

This paradigm shift enabling Intelligent Oversight provides scalability and flexibility to meet and exceed expectations, now and in the future.